Home
About
Overview
Sharing Data
ORCID
Help
History (22)
Developmental comorbidity of pain and depression in preadolescent girls
The use of fecal microbiota transplant in sepsis.
Using design methods to provide the care that people want and need.
Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer.
MELK inhibitor, novel molecular targeted therapeutics for human cancer stem cells.
See All 22 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MELK inhibitor, novel molecular targeted therapeutics for human cancer stem cells.
MELK inhibitor, novel molecular targeted therapeutics for human cancer stem cells. Cell Cycle. 2013 Jun 01; 12(11):1655-6.
View in:
PubMed
subject areas
Apoptosis
Cell Line, Tumor
Humans
Naphthyridines
Neoplasms
Neoplastic Stem Cells
Neuropeptides
Phosphorylation
Proteasome Endopeptidase Complex
Protein Kinase Inhibitors
authors with profiles
Yusuke Nakamura